You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Cryptococcosis

Showing 1 - 25 of 91
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Cryptococcosis in Previously Healthy Adults

Recruiting
  • Cryptococcus
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 25, 2023

    HIV/AIDS, Transitions of Care, Hospitalization Trial in Lusaka (Inpatient lab bundling, Inpatient navigation)

    Recruiting
    • HIV/AIDS
    • +5 more
    • Inpatient lab bundling
    • Inpatient navigation
    • Lusaka, Zambia
      University Teaching Hospital
    Jan 20, 2023

    Incidence of Opportunistic Fungal Infections

    Not yet recruiting
    • Pneumocystis Jirovecii Infection
    • +4 more
      • (no location specified)
      Jan 30, 2023

      Invasive Cryptococcosis Trial in Washington (ABLC)

      Withdrawn
      • Invasive Cryptococcosis
      • Washington, District of Columbia
        Washington Hospital Center
      Feb 15, 2021

      Scoring System to Distinguish Cryptococcosis and Adenocarcinoma

      Unknown status
      • Cryptococcosis
      • Lung Adenocarcinoma
      • A scoring system
      • Shanghai, Shanghai, China
        Shanghai pulmonary hospital
      Sep 17, 2020

      HIV, Tuberculosis, Cryptococcosis Trial in Battalapalli

      Recruiting
      • HIV
      • +4 more
        • Battalapalli, AP, India
          RDT Hospital
        Mar 8, 2021

        Cryptococcal Meningitis, Cryptococcus Neoformans, Cryptococcosis Trial in Kampala (Fluconazole)

        Completed
        • Cryptococcal Meningitis
        • +2 more
        • Kampala, Uganda
        • +1 more
        Jun 2, 2020

        Cryptococcosis, Cryptococcal Infections, AIDS-Related Opportunistic Infections Trial in Kampala (Sertraline, Placebo Oral

        Terminated
        Has Results
        • Cryptococcosis
        • +2 more
        • Kampala, Uganda
          Infectious Disease Institute, Makerere University
        Jun 2, 2020

        HIV +ve Cases With AIDS Defining Opportunistic Infections Among

        Completed
        • HIV Infections
        • +5 more
        • CD4 cell count
        • Khagaria, Bihar, India
          ART centre, Sadar Hospital
        Mar 18, 2020

        Candidiasis, Mycoses, HIV Trial in Tanzania, United States (Clotrimazole, Fluconazole)

        Completed
        • Candidiasis
        • +2 more
        • Palo Alto, California
        • +25 more
        Oct 26, 2021

        AIDS, Histoplasmosis AIDS, Tuberculosis Infection Trial in Mexico City (Histoplasma Urine Antigen Lateral Flow Antigen test,

        Not yet recruiting
        • Acquired Immunodeficiency Syndrome
        • +3 more
        • Histoplasma Urine Antigen Lateral Flow Antigen test
        • +2 more
        • Mexico City, Mexico
        • +3 more
        Jan 12, 2023

        Talaromycosis Using a Novel Antigen Test

        Recruiting
        • AIDS/HIV - RelatedDisease Associated With AIDS
          • Ho Chi Minh City, Ward 1 District 5, Vietnam
          • +1 more
          Feb 18, 2022

          Mycobacterium Abscessus Infection in Chronic Lung Disease and

          Enrolling by invitation
          • Mycobacterium Abscessus Infection
          • +2 more
          • Appropriate treatment
          • Pathum Wan, Bangkok, Thailand
            King Chulalongkorn Memorial Hospital
          Aug 31, 2022

          Meningitis, Cryptococcal, HIV Trial in Puerto Rico, United States (Flucytosine, Fluconazole, Amphotericin B)

          Completed
          • Meningitis, Cryptococcal
          • HIV Infections
          • Birmingham, Alabama
          • +13 more
          Oct 27, 2021

          The Study Will Focus on Assessing the Survival Benefit on an Enhanced Package of Care for Patients With Advanced HIV Disease

          Recruiting
          • The Study Will Focus on Assessing the Survival Benefit on an Enhanced Package of Care for Patients With Advanced HIV Disease
          • Enhanced care package
          • Kampala, Uganda
            kisugu health center IV
          Jul 9, 2022

          Meningitis, Cryptococcal, HIV Trial in United States (Itraconazole, Flucytosine, Fluconazole)

          Completed
          • Meningitis, Cryptococcal
          • HIV Infections
          • Los Angeles, California
          • +23 more
          Oct 26, 2021

          Strategy for Opportunistic Fungal Infections in AIDS Patients

          Recruiting
          • Opportunistic Fungal Infections
          • examination methods
          • Guangzhou, Guangdong, China
            Guangzhou Eighth People's Hospital, Guangzhou Medical University
          Dec 10, 2021

          Deep Mycosis Trial in Japan (AK1820, Voriconazole)

          Completed
          • Deep Mycosis
          • Nagakute, Aichi, Japan
          • +32 more
          May 13, 2021

          Relapsed or Refractory Chronic Lymphocytic Leukemia, Relapsed or Refractory Small Lymphocytic Lymphoma Trial in China

          Completed
          Has Results
          • Relapsed or Refractory Chronic Lymphocytic Leukemia
          • Relapsed or Refractory Small Lymphocytic Lymphoma
          • Beijing, Beijing, China
          • +15 more
          Sep 29, 2021

          Chronic Hepatitis B Trial in Auckland (TAF, TDF, Other approved antivirals)

          Completed
          Has Results
          • Chronic Hepatitis B
          • Auckland, New Zealand
            Auckland City Hospital
          Jun 7, 2022

          Candidemia, Mycoses, Fungal Infection Trial in Worldwide (Rezafungin for Injection, Caspofungin, Fluconazole)

          Completed
          Has Results
          • Candidemia
          • +3 more
          • Rezafungin for Injection
          • +4 more
          • Birmingham, Alabama
          • +131 more
          Dec 13, 2022

          B-cell Lymphoid Malignancies Trial in Australia, Korea, Republic of, United States (Zanubrutinib, Obinutuzumab)

          Completed
          Has Results
          • B-cell Lymphoid Malignancies
          • Fort Myers, Florida
          • +14 more
          Mar 1, 2022

          Lymphoma, Non-Hodgkin Trial in Worldwide (Copanlisib (Aliqopa, BAY80-6946))

          Active, not recruiting
          Has Results
          • Lymphoma, Non-Hodgkin
          • Copanlisib (Aliqopa, BAY80-6946)
          • Birmingham, Alabama
          • +100 more
          Feb 10, 2022

          Vietnam Cryptococcal Retention in Care Study - Version 2.1

          Unknown status
          • HIV/AIDS
          • +5 more
          • Preemptive high-dose Fluconazole
          • Hanoi, Vietnam
            National Hospital for Tropical Diseases
          Sep 10, 2017

          Innate Immune System With Risk for Cryptococcus Neoformans

          Completed
          • Cryptococcosis
            • Birmingham, Alabama
              University of Alabama
            Jun 30, 2017